| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Senti Biosciences, Inc. (SNTI) has 9 insiders with recent SEC Form 4 filings, including 0 buys and 4 sells. SNTI is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 639.6K | $630.1K | - | |
| Other | 74.8K | $73.7K | - | |
| Dir | 43.9K | $43.2K | - | |
| Dir | 21.9K | $21.6K | - | |
| Dir | 21.9K | $21.6K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 6, 2025 | Lu Timothy K | CEO | Sell | 4,467 | $4.11 | $18,338.74 | -2.6% | -23.3% | -78.5% | |
| Feb 6, 2025 | Rajangam Kanya77 | Pres. &Chief Med. &Dev. Off. | Sell | 1,479 | $4.11 | $6,074.13 | -7.8% | -23.3% | -78.5% |